Meta‐analysis of recombinant versus urinary‐derived FSH: an update

By Al‐Inany Hesham   Aboulghar Mohamed   Mansour Ragaa   Serour Gamal  

Human Reproduction, Vol. 18, Iss. 2, 2003-02 ,pp. : 305-313

Oxford University Press

Access to resources Recommend Favorite

Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis

By Coomarasamy Arri   Afnan Masoud   Cheema Deepti   van der Veen Fulco   Bossuyt Patrick M.M.   van Wely Madelon  

Human Reproduction, Vol. 23, Iss. 2, 2008-02 ,pp. : 310-315

Oxford University Press

Access to resources Recommend Favorite

Highly purified hMG achieves better pregnancy rates in IVF cycles but not ICSI cycles compared with recombinant FSH: a meta-analysis

By Al-Inany Hesham   Abou-Setta Ahmed   Aboulghar Mohamed   Mansour Ragaa   Serour Gamal  

Gynecological Endocrinology, Vol. 25, Iss. 6, 2009-06 ,pp. : 372-378

Informa Healthcare

Access to resources Recommend Favorite

Prion transmission in blood and urine: what are the implications for recombinant and urinary-derived gonadotrophins?

By Reichl H.  

Human Reproduction, Vol. 17, Iss. 10, 2002-10 ,pp. : 2501-2508

Oxford University Press

Access to resources Recommend Favorite

Clinical efficacy and cost-effectiveness of HP-human FSH (Fostimon®) versus rFSH (Gonal-F®) in IVF-ICSI cycles: a meta-analysis

By Gerli Sandro  

Gynecological Endocrinology, Vol. 29, Iss. 6, 2013-06 ,pp. : 520-529

Informa Healthcare

Access to resources Recommend Favorite